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Introduction live vaccines based on virulence, such as intermediate 
virulence and highly attenuated strains, while virulent  Infectious bursal disease (IBD) is a member of the 
vaccine  not  available  commercially  till  now.  The  family Birnaviridae [1]. It is an acute, highly contagious 
vaccine must be safe, pure and efficient [12]. Despite  viral disease of young chickens and characterized by an 
the vaccination tool in place for prevention of IBD in  enlargement of the bursa of fabricius and severs renal 
Egypt, some flocks are suffering from immunosuppre- damages [2]. IBD was first reported in Egyptian flocks 
ssion and mortality. Also some flocks up to 3weeks of  in the early seventies [3], however, interest in IBDV 
age (unsusceptible age of classical IBD) are immuno- antigenic  characterization  was  triggered  by  the 
suppressed  with  atrophied  bursa  and  lesion  of  appearance  of  the  very  virulent  IBD  in  vaccinated 
proventriculus. In addition, conventional live vaccines  Egyptian flocks [4,5]. Several reports have classified 
can be inhibited by maternal antibodies, making the  the  Egyptian  IBDV  isolates  as  classical  IBDV 
timing of vaccination difficult [13].  [5,6].Presently,  the  evidence  of  circulating  variant 
This study was carried out with an aim to prepare  IBDV  strains  were  isolated  from  flocks  vaccinated 
tissue culture vaccine from an isolated variant strain  with classical IBDV vaccines [7,8]. Variant strains of 
and possibility of cross protection between variant and  IBDV  are  usually  isolated  from  vaccinated  flocks. 
classical  one  as  a  method  of  prevention  of  IBD  These IBDV variants are antigenically different from 
infection. classic  strains  of  IBDVas  it  is  devoid  the  classical 
epitope(s)  defined  by  neutralizing  monoclonal  Material and Methods
antibodies [9]. Most of these epitopes are located in the 
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VP2 hyper variable region [10]. Very virulent IBDV  Committee has accorded permission for conducting 
(vvIBDV) strains have now spread all over the world  this trial.
[11]. Immunization is the principle method used for the 
Viral strains control of IBD in chickens. There are many available 
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Abstract
Aim: The present study was designed to evaluate live Gumboro (IBD) vaccine prepared from local variant isolated strain 
(Egy-IBD Var 2009 Vp2 gene-, partial cds submitted in gen bank at accession no. : JN 118617) for controlling IBD problem in 
Egypt.
Material and Methods: Local isolated variant strain was adapted on Baby Grivet Monkey kidney cell line -70(BGM-70) 
7.5 4.5 used for preparation of tissue culture (T.C) live vaccine. T.C IBDV had a titer of 10  TCID /ml (10  TCID per dose) after  50 50 
five passages in BGM-70 cell culture. Evaluation of prepared vaccine was done in vitro by measuring ELISA, and in vivo by 
protection % against very virulent or variant field IBD isolated strains. 
Result: Evaluation revealed that the prepared vaccine was safe; sterile; pure; non-immunosuppressive; and efficient. The 
Geometric Mean Titer (GMT) of ELISA for the prepared vaccine was 8271 and more than 10000 in compared with different 
commercial IBD vaccines; while protection percentage gave 96-100%; 92-96% and 96-98% in groups vaccinated with 
commercial (intermediate; intermediate plus and classical) IBD vaccines; respectively in compared to 96-100% in group 
vaccinated with local prepared vaccine when challenged with very virulent or variant IBD isolated strains.
Conclusion: We can use live T.C. IBD vaccine prepared from local variant isolated virus strain as method for control IBD 
disease in Egypt.
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Challenge very virulent IBD (vvIBD) and classic  solution;  Hank's  balanced  salt  solution  (HBSS); 
viruses: The viruses used in the challenge were in form  Minimum Essential Medium (MEM) were prepared 
of infectious allantoic fluid, they were isolated from  according  to  the  manufacturer's  instructions;  and 
field  cases  and  identified  by  PCR  and  sequence  Bovine serum was mycoplasma free and virus screened 
analysis. They were titrated in SPF ECE as described  "Gibco Limited, Scotland, and UK". The method used 
3.5  for inoculation in the microtitre plates was done [14].  by  [14]  with  titer10 EID /ml  and  it  is  calculated  50
Tissue culture used for detection of extraneous agents  according to the method of [15].
in prepared IBD vaccine (Avian Lymphoid Leucosis) 
Newcastle disease viruses (NDV): Newcastle disease  [19].
challenged virus: It is a virulent virus of Newcastle 
Propagation of local field isolates in BGM-70 cell lines:  disease  of  field  isolate,  it  was  obtained  from  the 
The local variant strain was adapted on Baby Grivet  Newcastle Disease Department, Veterinary Serum and 
Monkey Kidney cell line 70 (BGM-70). It was used for  Vaccine Research Institute, Abbassia, Cairo (VSVRI), 
6 variant virus propagation (attenuation) and titration  Its  infectivity  titer  was10   EID /ml.  It  used  for  50 [20]. It was obtained kindly from VacSera, Agouza;  challenge  the  experimental  chicks  3  weeks  post 
Giza. vaccination. 
Newcastle  disease  heamagglutinating  antigen:  Enzyme  linked  immuno-sorbent  assay  (ELISA):   
Propagation  of  Lasota  strain  NDV  in  embryonated  ELISA Kit was obtained from Symbiotic Corporation 
chicken  egg  was  applied  for  using  in  HI  test.  ND  11011 VIA Forntera San Digo; Infactious bursal kit 
Heamagglutinating antigen was adjusted 4 HA unite  with Batch no FS5155 [21] and Chicken anemia (CA) 
according to [16].  92127, U.S.; Leucosis ELISA Kit with Batch No. FS 
5254 as extraneous agents in locally prepared IBD TC  Vaccine strains
vaccine [19].ELISA Reader: Micro plate reader USA, 
Infectious bursal disease (IBD) vaccines:   Six live  VERSA max, with serial number was B02274.
attenuated  commercial  imported  gumboro  vaccine 
Polymerase chain reaction (PCR): PCR used for test of  were  used:  Three  intermediate;  IZOvac  Gumboro 
extraneous agents in IBD prepared vaccine and for  2with batch no. 0832F; Nobilis Gumboro 228E with 
detection the Identity of  IBD Vaccine [16]  by using  batch noA057A1N04&Gumbokal IM Fort SPF with 
DNA Star analysis; RNA extraction Kit using Bioflux  batch no 5085031.Two Intermediate plus; CevacIBDL 
simply total RNA extraction Kit Cat # BSC 52 S1).  with  batch  no.  5511Z3S4D&Cevac  GumboL  with 
DNA  extraction  Kit  using  Bioflux  Mega  Bio  virus  batch no 0201A2Y3B .Last one was Classical Nobils 
DNA purification kit cat # BSC 12 S14.  Amplification  Gumboro D78 with batch no.11601MM01.
by  using  BIOER  reverse  transcription  polymerase 
Newcastle disease vaccine : (vaccination of experi- chain reaction (RT–PCR) kit, one step cat # BSBO 7 MI 
mental chicks for evaluation of immunosuppressive  for (infectious bronchitis,, TRT and Avian Influenza) as 
effect of IBD vaccine) NDV Hitchner B1 vaccine strain  extraneous  RNA  agents  in  IBD  variant  vaccine. 
obtained from Intervet B.V., Box Meer Holland with  Amplification by using Ferments Dream Taq green  batch  no.  08811EJ01  Nobilis  ND  Hitchner.  This  PCR Master Mix Cat # K 1084 for (ILT, DH, Fowl Pox  vaccine used for immune- suppression study of IBD  and Marek's disease virus) as extraneous DNA agents  7.5 with titer 10 EID /ml. 50 in IBD variant vaccine .The amplicone was subjected 
Experimental hosts to sequencing. 
Experimental chicks: One day old specific pathogen  Haemagglutination test (HA): It carried out according 
free  (SPF)  chicks  were  obtained  from  the  SPF  to  the  standard  procedure  described  [22]  to  detect 
production farm, Koum Oshein, El-Fayoum, Egypt.  extraneous haemagglutinating agents in prepared IBD 
This farm is apart from Ministry of Agriculture. All  vaccine [17].
birds were housed in a separated negative pressure-
Haemagglutination inhibition (HI) test for NDV:  The  filtered air isolators and were provided with autoclaved 
test  was  carried  out  according  to  the  standard  commercial  water  and  feed.  The  chicks  used  for 
procedure described [22] for the haemagglutinating  evaluation of prepared vaccine study.
activity  of  NDV  antigen  was  an  essential  primary 
Specific pathogen free (SPF) embryonating chicken  procedure using the HA test to determine HA unites 
eggs (ECE): It was obtained from the SPF production 
used in HI test. farm, Koum Oshein, El-Fayoum, Egypt. Eggs were 
Titration of local field isolates in BGM-70 cell lines:   kept in the egg incubator at 37 °C with humidity 40-
This  method  was  carried  out  according  [14]  this  60% used for detection of extraneous haemagglutina-
technique used for evaluation of the potency of tissue  ting agents in prepared vaccine under test [17]. 
culture adopted live IBDV vaccines. The TCID was  50
Tissue cultures and cell culture media: Primary chicken  calculated [15].
embryo  fibroblast  cell  (CEF)  was  obtained  from 
Evaluation  of  bursal  lesion:  It  was  carried  out  Central  Lab  for  Evaluation  of Veterinary  Biologics 
according  to  Sharma  et  al.  [23].  Collected  bursa;  (CLEVB);  which  prepared  as  [18]. Trypsin-versine Available at www.veterinaryworld.org/Vol.6/Sept-2013/18.pdf
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spleen;  or  proventruclus  were  weighed  and  the  birds were observed daily for clinical signs attributable 
organ/body weight ratio was determined, also bursa  to ND infection.
weight index were estimated. - Forty SPF chicks were divided into 2 groups for 
studding the effect of the prepared live TCIBD variant 
Experimental design: Four experiments were design  vaccine  on  organs/body  weight  (bursa;  spleen  and  for evaluation of living IBD vaccine prepared from  rd th proventriculus) in relation to control birds at 3 ; 7 ;  locally variant isolated strain: th th 10 ; and14  after eye drop vaccination. -  Fifteen  SPF  one  day  old  chicks  were  used  in 
-  Four hundred and fifty SPF one day old chickens  determination the safety of the vaccine by eye drop 
were divided into equal nine groups. Groups from (1-  inoculation of ten field doses of locally prepared T.C 
6) vaccinated via eye drops with different commercial  IBD vaccine under test. While another 15 SPF chickens 
vaccines and group (7) was vaccinated with locally  were kept as control, all chickens were kept under 
prepared T.C variant vaccine. The birds in groups (8  observation for 3 weeks for any systemic reactions, and 
and 9) were kept as controls (+ve and -ve respectively).  post-mortem  examinations.  Five  chickens  of  each 
th th Chickens were kept under observation for 3 weeks post  group at 7 , 14  day post vaccination were sacrified for 
vaccination and the serum samples were collected from  investigation.  Bursa  of  fabricius  of  chickens  was 
all groups. The immune response was determined in  examined  macroscopically  for  evidence  of  any 
vitro by measuring ELISA titer post-vaccination and  changes due to IBDV infection.   Two groups of ten 
their mean antibody titer. All birds in vaccinated groups  Swiss mice each were used for monitoring safety in 
(1-8)  divided  into  two  sub  groups  (A  and  B)  to  mammalian  species.  Group  (1)  Vaccinated  group; 
determine the immune response in vivo by challenging  receive  the  T.C  IBD  vaccine  with  10  x  dose  intra  3.5 birds of subgroups (A) with 10 EID /dose vvIBDV  50 peritoneal,  and  group  (2);  were  non-vaccinated 
3.5 and subgroups (B) with 10 EID  / dose variant local  controlled group, All mice were kept under observation  50
isolated IBDV except group (9) which non vaccinated  for two weeks for any reaction.
non challenged. -  Four groups of 15 SPF chicks each were used for 
determination the immunosuppression of tested locally  Results
prepared T.C IBD vaccine. The vaccine under test was 
Preparation of live T.C. IBD vaccine from local variant  administered by eye drop, one field dose per bird, to 
strain: The local variant strain that was adapted on  each of 15 SPF chickens, at one day old (G1). A further 
BGM-70 cell line for preparation of living attenuated  three groups (G2-4) of birds of the same age and source 
vaccine. In Table-1, the results showed that BGM-70  are housed separately as controls. At 2 weeks of age, 
cell line was satisfactory as it yielded good cytopathic  each bird in groups (1 and 2) was given as one field 
changes  in  BGM-70  cell  started  after  7  days  post  dose of live Newcastle disease vaccine by eye-drop. 
inoculation (P.I) in the first passage, while the maximal  Birds of groups (3 and 4) were kept as control positive 
development of CPE was achieved at 2 days P.I. in the  and  negative  (+ve  and  -ve);  respectively.  The 
fifth passage. The observed cytopathic changes were  haemagglutination  inhibition  (HI)  response  of  each 
characterized  by  a  marked  granulation  of  cell  bird of four groups to Newcastle disease vaccine was 
cytoplasm,  cell  rounding,  cell  aggregation,  loss  of  monitored  two  weeks  after  the  administration  of 
adherence of cells and formation of cell syncytia. Newcastle  disease  vaccine,  and  the  protection  is 
6.0 measured  against  challenge  with  10 ELD   (50%  Determination  of  virus  titration  and  identity:  The  50
embryo lethal doses) field isolate of VVNDV which  virus titer increased in the higher passage than the 
administrated in each birds of groups (1, 2 and 3). All  lower ones as shown in Table-1 .The virus titer reached 
Table-1. Propagation and titration of local isolated IBD variant strain on BGM-
70 cell lines:
No. of passage Time needed for CPE Virus titer 
1 7 days 2.5
2 6 days 3.0
3 5 days 4.5
4 3 days 6.5
5 2 days 7.5
No. : Number CPE: cytopathic effect: titer of virus (log   TCID  / ml) 10 50
TCID  was calculated according to [15]. Titer of virus must be not less than 3.5 logs   50 10
TCID /dose according to [16]. 50
Figure-1. The PCR amplification of the spike 
gene of IBD polymerase gene under test.
The amplification of the 300bp fragment of 
vp gene of IBD virus indicated that IBD viral 
DNA was present [16].Available at www.veterinaryworld.org/Vol.6/Sept-2013/18.pdf
Veterinary World, EISSN: 2231-0916                    677
th disease  and  its  causative  agent  [26];  control  and  7.5 log  TCID  after 5  passages in BGM-70 cell line  10 50
vaccination in order to achieve good protection [27].  & identified by using PCR: primer specific to IBD 
This study was designated for preparation of T.C.  virus gives positive at 300bp amplification band which 
vaccine from local variant strain in compared with live  indicated that gumboro viral DNA was present (figure-1).
IBD  vaccines  that  used  in  the  field  as  method  of 
Determination  of  prepared  vaccine  purity  and  prevention the economic losses and the immunosu-
sterility: The results of live T.C IBD vaccine was free 
ppressive  effect  of  subclinical  form  of  IBD. Three  from bacterial; fungal & mycoplasma contamination. 
parameters were used in this study: vaccine preparation;  It  did  not  contain  any  extraneous  agent  either 
evaluation  and  efficacy  of  prepared  vaccine  by  haemagglutinating agent (Newcastle disease virus) by 
determination  of  immune  response  in  vitro  and  in  inoculation of 9 – 10 day old embryonated SPF eggs; 
vivo.   inoculation  of  primary  culture  of  chicken  embryo 
fibroblasts (Test for avian leucosis virus) or by using  Vaccine preparation: Preparation of live variant T.C. 
PCR test for another extraneous viral agents. IBD vaccine on BGM-70 cell which gave good results 
for  propagation  and  the  harvest  titration  (7.5  log   10 Safety of prepared vaccine: All vaccinated chickens 
TCID  / ml) as described by [28], and our results  50 had  no  changes  or  show  notable  clinical  signs  or 
agreed with the result obtained by [29] who used BGM- macroscopic lesions that are attributable to the vaccine 
70 cells successfully for isolation of IBDV from the  with comparison the negative control chickens. It also 
bursa of naturally infected chickens.  proved to be safe for mammalian species as there was 
no mortality occurred in any group, no general or local  Vaccine evaluation: The result of titration was judged 
reaction. Growth was identical in the all groups during  according to the parameters of [17] in which IBDV 
3.5  the period of observation .There was no evidence for  titers must be not less than 10 TCID  / dose. So the  50 abdominal  toxicity  in  Swiss  mice  inoculated  intra  prepared TC IBD variant strain was satisfactory with 
4.5  peritoneal with 10 X dose of T.C IBD vaccine. 10 TCID /dose.  The  results  of  sterility,  safety,  50
Potency test and cross protection: No clinical signs or  potency and immunogenicity of the local variant IBDV 
lesions were recorded in all vaccinated groups. After  was done according to [19, 30]. It is free from bacterial 
challenge with very virulent IBDV; birds in group (8- fungal and Mycoplasma which judged according to 
parameters of [31] in which the vaccine must be sterile  A)  (positive  control)  induce  approximately  100% 
and free from any contamination. The TCIBDV does  mortality;  atrophied  yellowish  bursas  with  slight 
not  contain  any  extraneous  agent  either  haemaggl- hemorrhages  on  proventriculus.  Protection  in  all 
utinating agent; avian leucosis virus or any another  vaccinated groups either challenged with vvIBDV or 
extraneous, viral agents when use SPF egg inoculation,  variant  IBDV  were  ranged  between  92-100%.  The 
tissue culture; ELISA test or PCR. These results were  protection in group (7) which vaccinated with TCIBD 
judged according to [17,31]. PCR used for detect of  (the vaccine under test) was in high percent (96-100%) 
identity  of  T.C  IBDV  as  described  in  [16].  All  as  shown  in  table  4.Birds  in  group  (8-B)  induce 
experimental chicks had no changes or show notable  approximately  80%  mortality  after  challenged  with 
clinical  signs  or  macroscopic  lesions  that  are  isolated  variant  IBDV  strain  and  bursas  atrophy; 
attributable to the vaccine in chicks vaccinated with  enlarged grey kidneys with slight enlarged in the spleen 
10X field dose in comparison with the negative control  in some cases & hemorrhage in proventriculus. While 
chicks.  Their  bursas  of  fabricius  were  examined  vaccinated birds in group (7B) induce 100% protection 
macroscopically for evidence of any changes due to  when challenged with isolated variant IBDv strain.  
IBDV. So that TCIBD vaccine which locally prepared 
Discussion from variant isolate was safe and sterile. Our results 
Different types of vaccines are mostly available  agreed with [32].The locally prepared variant T.C IBD 
for the prevention of IBD. These are live attenuated  vaccine is non-immunosuppressive as shown in Table -2. 
vaccine,  (egg  adapted  or  tissue  culture  one);  The  immunosuppression  has  been  most  often 
inactivated  oil-emulsion  adjuvant  vaccine  and  evidenced  using  experimental  models  based  the 
recombinant IBDV-vp2 protein vaccine as mentioned  measurement  of  humeral  responses  induced  by 
by [25]. Many recent authors have focused on IBD  Newcastle disease (ND) vaccines. The best assessment 
Table-2. Evaluation of the immunosuppressive effect of the prepared living TC IBD vaccine
No. of group No. of dead birds/ total number of birds Protection percentage Mean HI log  titer 2
to Newcastle disease vaccine
G1 vaccinated 2/15 86.6% 6.9
G2  Indicator 1/15 93.03% 7.2
G3 control +ve Non vaccinated & challenged 15/15 0% 1.9
G4 control –ve Non vaccinated non challenged 0/5 100% 1.9
As shown in Table-1, there was no significance difference (p<0.01) between HI titer in the vaccinated group in compare with indicator 
one so the locally prepared living attenuated T.C. variant strain is considered as non-immunosuppressive vaccine according to [16]. 
Mean of HI log2 titer for NDV must be not less than 6.0 to be protected according to [24]. Available at www.veterinaryworld.org/Vol.6/Sept-2013/18.pdf
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is  clearly  the  measurement  of  vaccine  protection  findings of [37].
against challenge infection by (ND) virus as described 
Efficacy of prepare vaccine: Four hundred and fifty  in [16]. Our results agreed with [30, 33] they studied  SPF one day old chickens were divided into equal nine  the effect of pathogenesis of commercially available  groups as in Table-4 for motoring TCIBDV immune  IBD vaccines and immune-suppressive effect. response. Six groups from (1- 6) vaccinated via eye  Bursa  indices  in  vaccinated  SPF  groups  were  drops  with  different  commercial  vaccines;  (three  significantly higher than the challenge control group  intermediate (1-3), two intermediate plus (4 and 5), one  Table-3. The TCIBD locally prepared variant vaccine  classical (6) and group (7) was vaccinated via eye drops  protected  against  bursa  damage  as  indicated  by  with locally prepared T.C variant vaccine. Birds in  significantly lower bursa lesions in vaccinated birds  groups (8 and 9) kept as controlled (+ve and -ve);  [34], the bursa from chickens with bursa/body weight 
respectively. Chickens were kept under observation for  index  higher  than  0.7  found  to  be  histologically 
3 weeks post vaccination and the serum samples were  normal. Bursa / Body weight ratio were calculated 
collected from all groups. The immune response was  according to [23].Bursa index (BI) equal to or less than 
determined in vitro by measuring ELISA titer post- 0.7 to be considered atrophy, the vaccinated group 
vaccination and their mean antibody titer. All birds in  revealed no bursa atrophy during 13 days PI. Variant 
vaccinated groups (1-8) divided into two sub groups (A  infected  group  revealed  marked,  rapid-decrease  in 
and B) to determine the immune response in vivo by  bursa size as early as 36 hours PI up to 13 days PI as  3.5  challenging  birds  of  subgroups  (A)  with  10 recorded in histopathology. Infected group with classic 
3.5 EID /dose vvIBDV and subgroups (B) with 10 EID  /  50 50 virus  strain  revealed  an  increase  in  bursa  size  to 
dose  variant  local  isolated  IBDV  except  group  (9)  approximately  twice  the  size  of  the  control  group 
which non vaccinated non challenged shown in table  within  4  days  PI,  then  decreased  in  size  to 
(4). No clinical signs or lesions were recorded in all  approximately half of the control group during 13 days 
vaccinated groups. After challenge with very virulent  PI bursa atrophy in this group begin to atrophied on the 
IBDV the birds in group (8-A) induce approximately  6th day PI (BI=0.53) to the end of the observation 
100% mortality; atrophied yellowish bursas with slight  period.  These  findings  are  in  agreement  with  the 
hemorrhages on proventriculus. Our results confirmed  findings  of  [35,36].Chickens  infected  with  local, 
in that reported by [2]. Protection % in intermediate  variant T.C IBDVs had larger splenic size and splenic 
vaccinated groups (1-3) was ranged between (98-100)  index (SI), mostly during the observation periods PI 
% for vvIBDv and from (96 -100) % for isolated variant  (from 36 hours to 14 days PI) as compared with control 
strain  while  GMT  ELISA  titer  (10610;  10251  and  ones.  These  findings  are  in  agreement  with  the 
11607);  respectively.  Intermediate  plus  vaccinated  assessment criteria proposed by [35], that splenic index 
groups (4 and 5) gave protection% (92 and 96) for  (SI), lower than the lowest control index considered 
vvIBDv and (94 and 96) for isolated variant strain with  atrophied, whereas an index higher than the highest 
GMT ELISA titer (10317 and 10927).Birds in group  control index was considered as hypertrophied. Based 
on these criteria, all IBDV infected groups showed  (6) gave 11092 with (96 and 98) protection%. GMT 
hypertrophied   spleens. These results agreed with the  ELISA  titer  was  8271  for TCIBD  locally  prepared 
Table-3. The effect of TCIBD variant vaccine on organs /body weight
B: bursa/body weight ratio, S: spleen /body weight ratio, P: proventriculus/body weight ratio Chicks with bursa index lower than 0.7 were 
considered to have bursa atrophy according to [23]. *significant difference at p<0.05
Treated groups of  No of SPF Chick O day 3 days 7 days 10 days 14 days
chicken B S P B S P B S P B S P
Vaccinated Group 20 0 *1.5 *1.3 1.0 1.4 *1.2 0.9 0.7 *0.4 1.0 0.7 0.7 0.9
Control, Non vaccinated 20 0 1 1 1 1 1 1 1 1 1 1 1 1
group
Table-4. Monitoring of potency and cross protection percentage
Group Type of vaccine used GMT of ELISA Protective % when challenged  Protective % when challenged 
3.5 3.5 by 10 EID /dose vvIBDV (A) by 10 EID /dose vvIBDV (B) 50 50
G1 Gumboro2 10610 98% 100%
G2 228E 10251 100% 100%
G3 Gumbokal 11607 98% 96%
G4 IBDL 10317 92% 94%
G5 GumboL 10927 96% 96%
G6 D78 11092 96% 98%
G7 TCIBD 8271 96% 100%
G8 Controlled +ve, non vaccinated 156 0% 20%
& challenged
G9 Controlled-ve, non vaccinated 156 100% 100%
&non challenged
The protective percent for vaccine must be equal or more than 90% [16]. GMT: Geometric mean of ELISA antibody titer against IBDV. 
 GMT of ELISA titer of control positive serum is equal or more than 3000 according to kit manufacture. Significant difference at P < 0.05Available at www.veterinaryworld.org/Vol.6/Sept-2013/18.pdf
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disease  In:Saif,  Y.M.,  Fadly,  A.  M.,  Glisson,  J.  R.,  vaccinated group (7).Protection% were 96 for birds in 
McDougald,  L.  R.,  Nolan,  L.K.,  Swayne,  D.E.  (Eds),  group  (7A).  While  vaccinated  birds  in  group  (7B)  th Disease  of  Poultry,12   ed.  Black  well  Publishing Ames  induce 100% protection when challenged with isolated  Iowa, USA. 
variant  IBDV  strain.  Birds  in  group  (8-B)  induce  3.  El-Sergany H.A., Ann, Moursi., Saber, M.S. and Mohamed, 
approximately  80%  mortality  after  challenged  with  M.A.(1974) A preliminary investigation on the occurrence 
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